Meg Tirrell joined CNBC in April 2014 as a general assignment reporter focusing on biotechnology and pharmaceuticals. She appears on CNBC's Business Day programming, contributes to CNBC.com and is based at the network's global headquarters in Englewood Cliffs, N.J.
Prior to joining CNBC, she led coverage of the biotechnology industry for Bloomberg News. She broke news on the proxy fights at Forest Labs and Vivus, the return of Ariad's cancer drug to market and the merger & acquisition story of Amylin Pharmaceuticals and Genzyme. She has written features that illuminate how science and business meet, and the effect on our health. She also contributed to Bloomberg Television and Bloomberg Businessweek.
She holds a master's degree in journalism from Northwestern University and a bachelor's degree in English and music from Wellesley College.
Follow her on Twitter @megtirrell.
CDC Director Dr. Tom Frieden provides insight to the spread of Ebola, and announces an individual traveling from Liberia to the United States has been diagnosed with Ebola in Texas.
CNBC's Meg Tirrell reports Texas health officials have confirmed the Ebola patient is in Texas, and had a recent history of travel to West Africa.
A new breast cancer drug from Roche showed "unprecedented" benefits in a clinical trial, reports CNBC's Meg Tirrell.